Upload Avatar (500 x 500)
Meng Xin
Life Science
China Medical University
Liaoning
Language: Chinese, English
Gene Transcription
Protein Expression
Tumorigenesis
Regulation
Drug Screening
Targeted Therapy
Cancer Research
Molecular Biology
Biochemistry
Disease Targeting
Areas of Focus
- Gene transcription and protein expression regulation related to tumorigenesis
- Drug screening targeting diseases
Work Experience
- Current - China Medical University - Professor, Deputy Director
Academic Background & Achievements
- Selected for Liaoning Province's 'Hundred, Thousand, and Ten Thousand Talents Project'
- National Natural Science Foundation of China Review Expert
Publications
- Enhanced Antitumor Effects of an Oncolytic Measles Virus Vaccine Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma, Meng Xin, 2024
- Knockdown of BAG3 induces epithelial mesenchymal transition in thyroid cancer cells through ZEB1 activation, Meng Xin, 2024
- Deficiency of caspase 3 in tumor xenograft impairs therapeutic effect of measles virus Edmoston strain, Meng Xin, 2024
- IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signalling pathway, Meng Xin, 2024
- ITGB3/CD61: a hub modulator and target in the tumor microenvironment, Meng Xin, 2024
- Development of an autophagy-related signature in pancreatic adenocarcinoma, Meng Xin, 2024
- Lack of FGF21 Promotes NASH-HCC Transition via Hepatocyte-TLR4-IL-17A Signaling, Meng Xin, 2024
- TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer, Meng Xin, 2024
Awards
- Liaoning Province Natural Science Second Prize: Role of ER stress, oxidative stress, and integrated stress in targeted therapy of thyroid tumors, Second Contributor, Certificate No: 2013J-2-55-02
- Shenyang Science and Technology Progress Award: Role of ER stress, oxidative stress, and integrated stress in targeted therapy of thyroid tumors, Second Contributor, Certificate No: 2013-2-41-2
